A longitudinal retrospective case series of the real-world toxicities encountered among cancer patients receiving anti-PD-L1 checkpoint inhibitor immunotherapy.

Anastasios L. Boutis,Aglaia Skolariki,Nikolaos Diamantopoulos,Alexandros Bokas,Georgios Chatsidis,Georgios Rizos,Pavlos Papakotoulas

A longitudinal retrospective case series of the real-world toxicities encountered among cancer patients receiving anti-PD-L1 checkpoint inhibitor immunotherapy.

2018

Anastasios L. Boutis
Aglaia Skolariki
Nikolaos Diamantopoulos
Alexandros Bokas
Georgios Chatsidis
Georgios Rizos
Pavlos Papakotoulas

e15117Background: Immunotherapy with anti-PD-L1 immune checkpoint inhibitors is currently a major component of systemic therapy in advanced solid tumors. Their toxicity profile has been well establ...

Keywords:

Physical therapy
Cancer
PD-L1
Immunotherapy
Medicine
Systemic therapy
Oncology
immune checkpoint inhibitors
toxicity profile
Internal medicine
Pathology
anti pd 1

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations